1
Nov 19 (Reuters) – Johnson & Johnson: * JOHNSON & JOHNSON SEEKS U.S. FDA APPROVAL FOR CAPLYTA IN BIPOLAR MANIA, MARKING FIFTH POTENTIAL INDICATION Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)